Loading insider details...
Beta
Latest Form 4 (Oct 8, 2025): Disposition to Issuer of 157,992 VRNA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2025 | Verona Pharma plc (VRNA) | Disposition to Issuer | 157,992 | n/a |
| Aug 6, 2025 | Verona Pharma plc (VRNA) | Exercise/Conversion | 24,000 | n/a |
| Apr 29, 2025 | Verona Pharma plc (VRNA) | Grant/Award | 96,000 | n/a |
| Aug 21, 2024 | Morphic Holding, Inc. (MORF) | Disposition to Issuer | 2,376 | n/a |
| Jun 20, 2024 | Inozyme Pharma, Inc. (INZY) | Grant/Award | 28,000 | n/a |
| Jun 5, 2024 | Morphic Holding, Inc. (MORF) | Grant/Award | 23,168 | n/a |
| Apr 30, 2024 | Verona Pharma plc (VRNA) | Grant/Award | 240,000 | n/a |
| Nov 22, 2023 | Verona Pharma plc (VRNA) | Purchase | 33,736 | $62.0K |
| Apr 28, 2023 | Verona Pharma plc (VRNA) | Grant/Award | 96,000 | n/a |
| Apr 29, 2022 | Verona Pharma plc (VRNA) | Grant/Award | 200,000 | n/a |